ClinVar Miner

Submissions for variant NM_000110.4(DPYD):c.545T>A (p.Met182Lys)

gnomAD frequency: 0.00002  dbSNP: rs779728902
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001779547 SCV002015188 uncertain significance not specified 2021-10-06 criteria provided, single submitter clinical testing Variant summary: DPYD c.545T>A (p.Met182Lys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 250952 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in DPYD causing Dihydropyrimidine Dehydrogenase Deficiency (4.8e-05 vs 0.0025), allowing no conclusion about variant significance. c.545T>A has been reported in the literature as a non-informative genotype in combination with other heterozygous sequence alterations in the DPYD gene in at-least one individual affected with partial Dihydropyrimidine Dehydrogenase Deficiency who demonstrated a severe toxicity to administration of 5-fluouracil (5-FU) (example, Ezzeldin_2003). It has subsequently been cited by others (example, Shahrokni_2009, Lazar_2004). These report(s) do not provide unequivocal conclusions about association of the variant with Dihydropyrimidine Dehydrogenase Deficiency. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in >50%-90% of normal DPYD enzyme activity (example, Shreshta_2018). Additionally, at-least one publication cites this variant among DPYD polymorphisms associated with a normal activity (example, Yoshida_2015). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.
Fulgent Genetics, Fulgent Genetics RCV002478006 SCV002776489 uncertain significance Dihydropyrimidine dehydrogenase deficiency 2021-11-15 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV002478006 SCV004049891 uncertain significance Dihydropyrimidine dehydrogenase deficiency 2023-04-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.